- Home
- SMSI vs ALLR Comparison
SMSI vs ALLR Comparison
Compare SMSI & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- ALLR
- Stock Information
- Founded
- SMSI 1982
- ALLR 2004
- Country
- SMSI United States
- ALLR United States
- Employees
- SMSI N/A
- ALLR N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- SMSI Technology
- ALLR Health Care
- Exchange
- SMSI Nasdaq
- ALLR Nasdaq
- Market Cap
- SMSI 15.9M
- ALLR 13.3M
- IPO Year
- SMSI 1995
- ALLR N/A
- Fundamental
- Price
- SMSI $0.90
- ALLR $1.00
- Analyst Decision
- SMSI Strong Buy
- ALLR
- Analyst Count
- SMSI 1
- ALLR 0
- Target Price
- SMSI $5.00
- ALLR N/A
- AVG Volume (30 Days)
- SMSI 103.7K
- ALLR 464.0K
- Earning Date
- SMSI 07-31-2025
- ALLR 08-04-2025
- Dividend Yield
- SMSI N/A
- ALLR N/A
- EPS Growth
- SMSI N/A
- ALLR N/A
- EPS
- SMSI N/A
- ALLR N/A
- Revenue
- SMSI $19,378,000.00
- ALLR N/A
- Revenue This Year
- SMSI $10.12
- ALLR N/A
- Revenue Next Year
- SMSI $63.12
- ALLR N/A
- P/E Ratio
- SMSI N/A
- ALLR N/A
- Revenue Growth
- SMSI N/A
- ALLR N/A
- 52 Week Low
- SMSI $0.52
- ALLR $0.61
- 52 Week High
- SMSI $2.57
- ALLR $7.45
- Technical
- Relative Strength Index (RSI)
- SMSI 55.29
- ALLR 54.51
- Support Level
- SMSI $0.85
- ALLR $0.80
- Resistance Level
- SMSI $0.98
- ALLR $1.09
- Average True Range (ATR)
- SMSI 0.07
- ALLR 0.07
- MACD
- SMSI 0.01
- ALLR 0.02
- Stochastic Oscillator
- SMSI 69.75
- ALLR 63.03
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.